OncoVerity logo

OncoVerity Funding & Investors

Aurora, CO

OncoVerity focuses on optimizing and advancing the development of cusatuzumab, a novel anti-CD70 antibody.

oncoverity.com

Total Amount Raised: $44,000,000

OncoVerity Funding Rounds

  • Series A

    $14,000,000

    Series A Investors

    argenx
    RefinedScience

  • Series A

    $30,000,000

    Series A Investors

    argenx
    University License Equity Holdings
Funding info provided by Diffbot.